Schnog JB - Search Results

1

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.

Schnog JB, Teerlink T, van der Dijs FP, Duits AJ, Muskiet FA; CURAMA Study Group. Schnog JB, et al. Ann Hematol. 2005 May;84(5):282-6. doi: 10.1007/s00277-004-0983-3. Epub 2004 Dec 14. Ann Hematol. 2005. PMID: 15599544

2

Elevated IL-8 levels during sickle cell crisis.

Duits AJ, Schnog JB, Lard LR, Saleh AW, Rojer RA. Duits AJ, et al. Among authors: schnog jb. Eur J Haematol. 1998 Nov;61(5):302-5. doi: 10.1111/j.1600-0609.1998.tb01092.x. Eur J Haematol. 1998. PMID: 9855244

3

Plasma homocysteine levels in sickle cell disease and the need for folate supplementation.

Schnog JB, van der Dijs FP, Brouwer DA, Duits AJ, Muskiet FD, Muskiet FA. Schnog JB, et al. J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):184-5; author reply 185-6. doi: 10.1097/00043426-200003000-00022. J Pediatr Hematol Oncol. 2000. PMID: 10779038 Clinical Trial. No abstract available.

4

Duffy phenotype does not influence the clinical severity of sickle cell disease.

Schnog JB, Keli SO, Pieters RA, Rojer RA, Duits AJ. Schnog JB, et al. Clin Immunol. 2000 Sep;96(3):264-8. doi: 10.1006/clim.2000.4884. Clin Immunol. 2000. PMID: 10964545

5

Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study.

Schnog JB, Kater AP, Mac Gillavry MR, Duits AJ, Lard LR, van Der Dijs FP, Brandjes DP, ten Cate H, van Eps LW, Rojer RA. Schnog JB, et al. Am J Hematol. 2001 Nov;68(3):179-83. doi: 10.1002/ajh.1175. Am J Hematol. 2001. PMID: 11754399 Free article. Clinical Trial.

6

Folate status assessment and folic acid supplements in sickle cell disease.

Schnog JB, van der Dijs FP, Fokkema MR, Muskiet FD, Muskiet FA. Schnog JB, et al. J Pediatr Hematol Oncol. 2001 Nov;23(8):548. doi: 10.1097/00043426-200111000-00015. J Pediatr Hematol Oncol. 2001. PMID: 11878785 No abstract available.

7

No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease.

Schnog JB, Mac Gillavry MR, Rojer RA, Meijers JC, Fijnheer R, ten Cate H, Brandjes DP, Duits AJ. Schnog JB, et al. Am J Hematol. 2002 Sep;71(1):53-5. doi: 10.1002/ajh.10178. Am J Hematol. 2002. PMID: 12221677 Free article.

8

Steady-state sVCAM-1 serum levels in adults with sickle cell disease.

Schnog JB, Rojer RA, Mac Gillavry MR, Ten Cate H, Brandjes DPM, Duits AJ. Schnog JB, et al. Ann Hematol. 2003 Feb;82(2):109-113. doi: 10.1007/s00277-003-0609-1. Epub 2003 Feb 11. Ann Hematol. 2003. PMID: 12601490

9

Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease.

Duits AJ, Rojer RA, van Endt T, MacGillavry MR, ten Cate H, Brandjes DP, Schnog JB. Duits AJ, et al. Among authors: schnog jb. Ann Hematol. 2003 Mar;82(3):171-4. doi: 10.1007/s00277-003-0610-8. Epub 2003 Feb 13. Ann Hematol. 2003. PMID: 12634950

10

Protein C and S and inflammation in sickle cell disease.

Schnog JB, Mac Gillavry MR, van Zanten AP, Meijers JC, Rojer RA, Duits AJ, ten Cate H, Brandjes DP. Schnog JB, et al. Am J Hematol. 2004 May;76(1):26-32. doi: 10.1002/ajh.20052. Am J Hematol. 2004. PMID: 15114593 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters